The Guardian view on de-extinction: Jurassic Park may be becoming reality
By Editorial,
The Guardian
| 08. 19. 2022
We should be keeping endangered species alive rather than bringing animals back from extinction
"tasmanian tiger" by nicolas.boullosa is licensed under CC BY 2.0.
The last official sighting of a Tasmanian tiger in the wild occurred in 1930, when it was shot by a farmer. The marsupials, formally known as thylacines, were hunted to extinction by European settlers who considered them a threat to their sheep and poultry. However, the 6ft-long creatures may reappear if a group of biotechnologists have their way.
The company Colossal Biosciences, along with researchers from the University of Melbourne, plans to “de-extinct” the thylacine by using gene-editing technology. Australia has the fastest rate of mammal extinction in the world; disappearances are down to the arrival of foreign species and wildfires linked to the climate crisis. Scientists argue that in Tasmania the loss of the thylacine left the numbers of smaller marsupials unchecked, leading to over-grazing and threatening a fragile ecological balance.
If it all sounds like a plot line from Jurassic Park, then that is because the science behind the resurrection plan provided the movie’s inspiration. Last year Colossal, co-founded by a Harvard geneticist, raised...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...